Alternatives to EfA Technologies

Sight Diagnostics develops rapid, accurate, and convenient diagnostic testing solutions, including a complete blood count analyzer.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Develops in-vitro diagnostic platforms for rapid antimicrobial susceptibility testing.

Develops a point-of-care diagnostic platform for rapid and accurate disease detection.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing breath-based diagnostics for lung diseases.

Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.

Developing wearable brain imaging systems using quantum sensing technology.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Epitel develops AI-driven wireless brain health technologies for remote EEG monitoring, improving diagnosis and management of neurological conditions like epilepsy.

Developing novel immunotherapies and diagnostics for cancer.

AI-powered respiratory diagnosis for faster and more accessible lung disease testing.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Revolutionizing electrophysiology with innovative, wireless, wearable Smart Skin technology for advanced monitoring.

Integrated life science company specializing in diagnostic testing solutions and life science raw materials.

AI-powered blood test for early cancer detection and subtyping.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.